Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Randomized, Controlled, 48-Week Study of Switching Stavudine and/or Protease Inhibitors to Combivir/Abacavir to Prevent or Reverse Lipoatrophy in HIV-Infected Patients
PaperCitations, authors & open-access status
Randomized, Controlled, 48-Week Study of Switching Stavudine and/or Protease Inhibitors to Combivir/Abacavir to Prevent or Reverse Lipoatrophy in HIV-Infected Patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 113 citations, 2003 year and closed oa status.
113
Citations
2003
Year
closed
OA Status